Heng Lungh Choo

Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF)

Boon Shing Tan, Kai Hung Tiong, Heng Lungh Choo et al. · Cell Death and Disease · 2015 · 150 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival

Kai Hung Tiong, Boon Shing Tan, Heng Lungh Choo et al. · Oncotarget · 2016 · 88 citations · Full text

Medicine, Cancer Biology, Oncology +16

Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73

Su Wei Wong, Kai Hung Tiong, Weng Yip Kong et al. · Breast Cancer Research and Treatment · 2010 · 82 citations

Medicine, Oncology, Pharmacology +12

CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

Boon Shing Tan, Kai Hung Tiong, Ashwin Muruhadas et al. · Molecular Cancer Therapeutics · 2011 · 68 citations

Medicine, Oncology, Pharmacology +13

Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells

Soon Yang Low, Boon Shing Tan, Heng Lungh Choo et al. · Cancer Letters · 2011 · 43 citations

Medicine, Cell Biology, Oncology +14